The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis.
The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis.
复制标题
DOI:
10.1186/ar2995
复制
发表时间:
2010
影响因子:
4.9
通讯作者:
Kvien TK
中科院分区:
文献类型:
--
作者:
Mjaavatten MD;van der Heijde D;Uhlig T;Haugen AJ;Nygaard H;Sidenvall G;Helgetveit K;Kvien TK
We wanted to assess the importance of the levels of anti-citrullinated peptide antibody (anti-CCP) and immunoglobulin M (IgM) rheumatoid factor (RF) in predicting development of persistent arthritis from undifferentiated arthritis (UA), and to investigate whether there is an added predictive value for persistent arthritis in testing for both anti-CCP and IgM RF. Patients with UA (exclusion of definite non-rheumatoid arthritis (RA) diagnoses) included in the Norwegian very early arthritis clinic were assessed for development of persistent arthritic disease. The effect of antibody level on the likelihood of persistent arthritis was investigated, and the sensitivity and specificity for persistent arthritis for anti-CCP and IgM RF, separately and combined, was determined. A total of 376 UA patients were included (median arthritis duration 32 days). 59 (15.7%) patients were IgM RF positive, and 62 (16.5%) anti-CCP positive. One hundred, seventy-four (46.3%) had persistent disease after one year. Overlap of anti-CCP and IgM RF positivity was 58%. Sensitivity/specificity for persistent arthritis was 28/95% for IgM RF alone, 30/95% for anti-CCP alone, and 37/92% for positivity of both anti-CCP and IgM RF. The likelihood for persistent disease increased with increasing levels of both anti-CCP and IgM RF. The likelihood of developing persistent arthritis in UA patients increases with the level of anti-CCP and IgM RF. Testing both anti-CCP and IgM RF has added predictive value in UA patients. This study suggests that antibody level should be taken into account when making risk assessments in patients with UA.
登录
查看更多内容
影响因子:
5.5
作者:
Scott, DL
通讯作者:
Scott, DL
DOI:
10.3899/jrheum.080895
发表时间:
2009-04
期刊:
The Journal of rheumatology
影响因子:
--
作者:
Chibnik LB;Mandl LA;Costenbader KH;Schur PH;Karlson EW
通讯作者:
Karlson EW
影响因子:
27.4
作者:
Bos, W. H.;Wolbink, G. J.;van Schaardenburg, D.
通讯作者:
van Schaardenburg, D.
影响因子:
3.4
作者:
Kudo-Tanaka, Eriko;Ohshima, Shiro;Saeki, Yukihiko
通讯作者:
Saeki, Yukihiko
影响因子:
2.1
作者:
KAARELA, K;KAUPPI, MJ;LEHTINEN, KES
通讯作者:
LEHTINEN, KES